Methotrexate Injection BP 25 mg

Methotrexate Injection BP 25 MG is a prescription medication used for various conditions, including certain types of cancer and autoimmune disorders. This intravenous solution is manufactured by Accord Healthcare Inc. in Canada.

Methotrexate Injection BP 25 MG is commonly used in the treatment of certain types of cancer, such as leukemia and lymphoma. It is also used to manage severe rheumatoid arthritis and psoriasis when other treatments have not been effective. The medication works by interfering with the growth of certain cells in the body. Always consult a healthcare provider to determine if this medication is suitable for your condition.

Common effects of Methotrexate Injection BP 25 MG may include nausea, vomiting, and fatigue. Some individuals may experience mouth sores or hair loss. These effects can vary widely depending on the individual and the specific condition being treated. It is important to discuss any concerns about side effects with a healthcare professional.

Methotrexate Injection BP 25 MG should be handled with care and administered under the supervision of a healthcare provider. It is important to follow the prescribed dosage and schedule. Pregnant women or those planning to become pregnant should avoid this medication due to potential risks. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Methotrexate Injection BP 25 MG can interact with various medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), certain antibiotics, and other drugs that affect the immune system. Alcohol consumption should be avoided as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication while using Methotrexate.